Category:

Farmers...are growing plants in an unconventional way so they can "milk" them for rare molecules that could be used in medicines, cosmetics and agrochemicals... major companies,..BASF and Chanel, have teamed up with Plant Advanced Technologies in the hope of securing...the so-called biomolecules it extracts through the use of a patented technique.

Ethiopia will start making its own APIs in 2020 according to the government which says local manufacture will improve access to medicines, curb sale of counterfeits and promote innovation…aspires to be self-reliant in essential medicines

still looks more like...Target...but in a few months will be the new home of the Southern Nevada Health District...new center will include environmental health services, immunizations, nursing clinic services, Food Handler Safety Training services, EMS services, epidemiology, informatics, public health preparedness and disease investigation.

When it comes to electric health records (EHR), many docs are more frustrated than ever. "They have so much potential to improve healthcare, improve quality, improve our efficiency, improve patient engagement, and yet that's not the current state of reality,"… "Our experience as physicians is often falling far short of the promise…"

Arrangements will improve oversight of medicines for better protection of public and animal health...European Medicines Agency and the European Commission's Directorate General for Health and Food Safety have agreed with the Swiss Agency for Therapeutic Products and the Swiss Federal Department of Home Affairs to share non-public information on the safety, quality and efficacy of medicines,...

Two very different eye treatments have won backing from the National Institute for Health and Care Excellence for...diabetic macular oedema, paving the way for their use by the National Health Service (United Kindom)...Eylea (aflibercept) and implant Ozurdex (dexamethasone)

Amgen Inc. won approval in the European Union for its drug Repatha, the first regulatory clearance for a new class of powerful cholesterol-lowering drugs… for patients with uncontrolled cholesterol who require additional intensive reduction of low density lipoprotein...

International Academy of Compounding Pharmacists has raised serious concerns about patient access to vital medications..."FDA’s draft guidance overreaches far beyond the intentions of Congress and contradicts the clear language of the DQSA and previous federal legislation....it will hinder patient access to compounded medications, limit patient choice of their pharmacist, and disrupt the essential physician-patient-pharmacist triad relationship,"

federal appeals court has ruled that Novartis can begin selling its lower-cost copy of an Amgen Inc. drug (Zarxio biosimilar to Neupogen)....rejecting a bid to further delay the launch of the knock-off biotech medication.

FDA sent a warning letter to Vista Pharmaceuticals, which is based in India, for not paying Generic Drug User Fee Act fees on time. This is the fourth time this month.. Failure to pay... fees is an international problem. This month alone, companies in India, the U.S. and China were fined for failure to pay in a timely manner.